News | April 12, 2024
Generics gain ground, yet HCPs still favor branded drugs, finds GlobalData
A significant proportion of healthcare professionals still tend to favor branded drugs
A significant proportion of healthcare professionals still tend to favor branded drugs
The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD) Prozac Tablets of Eli Lilly
This is the fourth authorized indication in Europe for Reblozyl, a first-in-class treatment for patients with disease-related anemia
Produodopa is the first-and-only subcutaneous 24-hour infusion of levodopa-based therapy for the treatment of severe motor fluctuations
The agreement grants Brinter the distribution rights of GrowInk bioinks in many countries
The full transition of Viatris' biosimilars operations to Biocon Biologics in Europe represents another significant milestone
Nerivio is a prescription-based non-invasive device intended for acute and prophylactic (preventive) treatment of migrain
Tagrisso is projected to be a pivotal contributor to AstraZeneca’s portfolio
The introduction of 'Definisse Core Filler' is a testament to the company's premium scientific-based innovation
Approval of this product under the PEPFAR program completes Strides’ qualification to all major markets and donor programs including Global Fund and South Africa
Subscribe To Our Newsletter & Stay Updated
